VCE is one of the evolving techniques for the investigation of the small intestine that may not be accessible to conventional endoscopy techniques, such as EGD and colonoscopies. In cases of obscure ...
CapsoVision, a medical device company, submitted a 510(k) application to the FDA for an AI-assisted module designed for its CapsoCam Plus capsule endoscopy platform. The tool aims to improve ...
Orlando, Tuesday, May 20, 2003 -- Video capsule endoscopy is a novel technology that is designed primarily to image the small intestine. The current version of the capsule is called the M2A Plus ...
Though generally reliable, current modalities used to diagnose and assess CD are imperfect. SBCE has been found to be a safe and effective alternative to endoscopy for both diagnosing and monitoring ...
Company Preparing to Commence Commercialization Following U.S. FDA 510(k) ClearanceSARATOGA, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical ...
Please provide your email address to receive an email when new articles are posted on . While both tests “have an important positive impact on the diagnosis and management of small-bowel diseases,” ...
Discover the groundbreaking capsule endoscopy—a tiny, wireless camera encased in a transparent pill-sized capsule. This ...
TipRanks on MSN
CapsoVision seeks FDA clearance for AI endoscopy module
CapsoVision, Inc. ( ($CV) ) has shared an announcement. On December 29, 2025, CapsoVision, Inc. announced it had submitted a 510(k) application to ...
Please provide your email address to receive an email when new articles are posted on . The diagnostic yields of video capsule endoscopy and double-balloon enteroscopy for indications without bleeding ...
In a pooled analysis involving over 2,300 patients, purgative preparations were linked to a 15% improvement in adequate small bowel cleansing (pooled rate difference [RD] 0.15) compared with fasting ...
Thought LeadersAndrea DoolanCEO and co-founderAtlantia Food Clinical Trials In this interview, Andrea Doolan, CEO and co-founder of Atlantia Clinical Trials, describes a case study trial on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results